1. Protecting American Innovation. The Hill;Stivers,2018
2. PhRMA Statement on STRONGER Patents Act,2018
3. BIO Statement of Support for the Introduction of the STRONGER Patents Act,2018
4. Concerns about S. 1390, the STRONGER Patents Act of 2017;Letter,2017
5. Drug Inter Partes Review (IPR) Is Necessary to Lower Drug Prices by Ensuring that PTO Only Grants Patents that Reflect True Innovation;Aam,2018